Physician

Mridula A George

According to 2025 Medicare claims, Mridula George (NPI: 1285997569) practices hematology in the Lakewood-New Brunswick, NJ market, with the plurality of this provider's patient population coming from Middlesex, NJ. This provider's primary affiliated billing organization is RUTGERS HEALTH-RWJ SCLERODERMA PROGRAM (NPI: 1518904929; TIN: 223371727) and primary practice location at 08901-1992. George is affiliated with the Vytalize Health 9 ACO LLC (ACO ID: D0313), participating under the REACH model.

George's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 129 traditional Medicare patients, billed 408 HCPCS/CPT codes, and received $31,444 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 523 prescription claims across 157 beneficiaries totaling $960,570 in drug costs, led by Ibrance (Palbociclib). DME data shows 12 claims. Open Payments data shows 57 records totaling $836,437. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $2,556 to $960,570. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	18	26	$3,271
2019	96	266	$31,914
2020	88	265	$29,712
2021	92	280	$33,307
2022	94	248	$28,220
2023	109	259	$25,860
2024	129	408	$31,444

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	26	56	$2,556
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	54	214	$164,832
2020	75	387	$489,007
2021	87	329	$206,789
2022	97	347	$468,276
2023	135	454	$485,628
2024	157	523	$960,570

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	12	$333

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	13	13	$146
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	31	31	$141
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	35	106	$119
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	68	108	$74
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	63	115	$14

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ibrance	Palbociclib	47	1,309	$731,927
Exemestane	Exemestane	16	1,380	$6,536
Letrozole	Letrozole	179	15,560	$4,835
Tamoxifen Citrate	Tamoxifen Citrate	88	7,380	$2,152
Anastrozole	Anastrozole	52	3,873	$989

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J8521	Capecitabine, oral, 500 mg	N	N/R	12	$333

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	5	$215	BioNTech SE
Research Payments	Reported research-related payment or transfer-of-value amount.	52	$836,222	PFIZER INC.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mridula A. George?

Tedicare shows public-source Medicare data for Mridula A. George (NPI 1285997569), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mridula A. George have ACO affiliation data?

Mridula A. George is shown with ACO affiliation data for Vytalize Health 9 ACO LLC (REACH, ACO ID D0313).

What billing organization is linked to Mridula A. George?

Mridula A. George is linked to RUTGERS HEALTH-RWJ SCLERODERMA PROGRAM (billing NPI 1518904929) in the available physician profile data.

Does Mridula A. George have Open Payments data?

Mridula A. George has 57 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.